Compare, Analyse Orchid Pharma with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA vs MYLAN (US) - Comparison Results

ORCHID PHARMA     Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

MYLAN (US)
   Change

Mylan is one of the worlds leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industrys broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ORCHID PHARMA   MYLAN
EQUITY SHARE DATA
    ORCHID PHARMA
Sep-13
MYLAN
Dec-18
ORCHID PHARMA/
MYLAN
5-Yr Chart
Click to enlarge
High Rs1943,589-   
Low Rs351,975-   
Sales per share (Unadj.) Rs276.51,651.5-  
Earnings per share (Unadj.) Rs-79.244.8-  
Cash flow per share (Unadj.) Rs-43.5354.1-  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs53.91,786.6-  
Shares outstanding (eoy) m70.45514.50-   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x0.41.7 24.6%   
Avg P/E ratio x-1.462.0 -2.3%  
P/CF ratio (eoy) x-2.67.9 -33.5%  
Price / Book Value ratio x2.11.6 136.3%  
Dividend payout %00-   
Avg Mkt Cap Rs m8,0671,431,473 0.6%   
No. of employees `0002.835.0 8.0%   
Total wages/salary Rs m2,5270-   
Avg. sales/employee Rs Th6,956.124,276.6 28.7%   
Avg. wages/employee Rs Th902.50-   
Avg. net profit/employee Rs Th-1,993.0659.2 -302.3%   
INCOME DATA
Net Sales Rs m19,477849,683 2.3%  
Other income Rs m4070-   
Total revenues Rs m19,884849,683 2.3%   
Gross profit Rs m1,103219,866 0.5%  
Depreciation Rs m2,519159,094 1.6%   
Interest Rs m5,22740,867 12.8%   
Profit before tax Rs m-6,23619,906 -31.3%   
Minority Interest Rs m200-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m5110-   
Tax Rs m-125-3,167 4.0%   
Profit after tax Rs m-5,58023,072 -24.2%  
Gross profit margin %5.725.9 21.9%  
Effective tax rate %2.0-15.9 -12.6%   
Net profit margin %-28.72.7 -1,055.1%  
BALANCE SHEET DATA
Current assets Rs m11,014474,462 2.3%   
Current liabilities Rs m32,060345,935 9.3%   
Net working cap to sales %-108.115.1 -714.4%  
Current ratio x0.31.4 25.0%  
Inventory Days Days9584 113.5%  
Debtors Days Days3493 36.0%  
Net fixed assets Rs m29,440164,824 17.9%   
Share capital Rs m705452 155.7%   
"Free" reserves Rs m2,0430-   
Net worth Rs m3,800919,201 0.4%   
Long term debt Rs m9,018992,113 0.9%   
Total assets Rs m46,5102,465,655 1.9%  
Interest coverage x-0.21.5 -13.0%   
Debt to equity ratio x2.41.1 219.9%  
Sales to assets ratio x0.40.3 121.5%   
Return on assets %-0.82.6 -29.3%  
Return on equity %-146.92.5 -5,850.6%  
Return on capital %-3.73.2 -117.5%  
Exports to sales %37.90-   
Imports to sales %22.60-   
Net fx Rs m1,8650-   
CASH FLOW
From Operations Rs m1,682176,564 1.0%  
From Investments Rs m-9,860-91,264 10.8%  
From Financial Activity Rs m6,644-82,254 -8.1%  
Net Cashflow Rs m-1,5351,463 -104.9%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 75.4 Rs / USD

Compare ORCHID PHARMA With: ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare ORCHID PHARMA With: BIOCON   WOCKHARDT  SHASUN PHARMA  ALKEM LABORATORIES  DIVIS LABORATORIES  



Today's Market

Sensex Ends 244 Points Lower, Nifty Ends Below 14,300; UltraTech Cement & HCL Tech Top Losers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended lower.

Related Views On News

Most Popular

India: Recovery Stalled by Vaccine Games? (The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

A Stock with 700% Return Potential Comes with Additional Payoffs (Profit Hunter)

Apr 15, 2021

Narayana Murthy was one of the first unicorn founders to get the backing of this entity...

11x Bankruptcy to Bluechip Stock: A Rare India Revival Story (Profit Hunter)

Apr 16, 2021

There is no stopping this 11-bagger stock from significant upside.

Top 3 Nifty ETFs to Buy Now (Fast Profits Daily)

Apr 20, 2021

In this video I tell you the three Nifty ETFs I think are the best.

Why Did the Market Crash on Monday? (Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

ORCHID PHARMA SHARE PRICE


Apr 20, 2021 (Close)

TRACK ORCHID PHARMA

  • Track your investment in ORCHID PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ORCHID PHARMA

ORCHID PHARMA 5-YR ANALYSIS

COMPARE ORCHID PHARMA WITH

FEATURED VIDEOS

Stability, Quality or Green Stocks for 2021?

Market Crash: Picture Abhi Baaki Hai?

It's a Great Time to Buy Gold

The Dilemma of Investing in Bharti Airtel

More Featured Videos

MARKET STATS